23.63
price down icon5.37%   -1.34
after-market Dopo l'orario di chiusura: 23.63
loading
Precedente Chiudi:
$24.97
Aprire:
$25.01
Volume 24 ore:
607.45K
Relative Volume:
1.22
Capitalizzazione di mercato:
$1.10B
Reddito:
$722.68M
Utile/perdita netta:
$134.71M
Rapporto P/E:
8.8502
EPS:
2.67
Flusso di cassa netto:
$109.94M
1 W Prestazione:
-11.66%
1M Prestazione:
-16.80%
6M Prestazione:
+0.47%
1 anno Prestazione:
-48.95%
Intervallo 1D:
Value
$23.20
$25.02
Intervallo di 1 settimana:
Value
$23.20
$27.07
Portata 52W:
Value
$20.39
$53.95

Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile

Name
Nome
Amphastar Pharmaceuticals Inc
Name
Telefono
909-980-9484
Name
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Name
Dipendente
2,028
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-06
Name
Ultimi documenti SEC
Name
AMPH's Discussions on Twitter

Confronta AMPH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
AMPH
Amphastar Pharmaceuticals Inc
23.63 1.16B 722.68M 134.71M 109.94M 2.67
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.11 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.71 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.00 20.14B 3.08B 1.24B 1.07B 25.61

Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-12 Aggiornamento Needham Hold → Buy
2025-05-12 Downgrade JP Morgan Overweight → Neutral
2025-02-04 Downgrade Piper Sandler Overweight → Neutral
2024-11-22 Iniziato Wells Fargo Equal Weight
2024-03-05 Iniziato JP Morgan Overweight
2023-11-17 Iniziato BofA Securities Neutral
2023-07-25 Ripresa Jefferies Buy
2022-10-21 Ripresa Jefferies Buy
2022-07-29 Iniziato CapitalOne Overweight
2022-01-07 Aggiornamento Piper Sandler Neutral → Overweight
2021-01-08 Downgrade Wells Fargo Overweight → Equal Weight
2020-10-05 Aggiornamento Northland Capital Market Perform → Outperform
2020-05-01 Iniziato Northland Capital Outperform
2019-03-13 Downgrade Needham Buy → Hold
2019-03-13 Downgrade Piper Jaffray Overweight → Neutral
2018-08-10 Reiterato Needham Buy
2018-03-13 Reiterato Needham Buy
2017-12-01 Reiterato Needham Buy
2017-11-09 Downgrade Raymond James Outperform → Mkt Perform
2017-09-27 Reiterato Needham Buy
2017-03-14 Downgrade Raymond James Strong Buy → Outperform
2016-08-09 Reiterato Needham Buy
2016-05-10 Reiterato Needham Buy
2016-02-19 Iniziato Wells Fargo Outperform
2015-06-19 Reiterato Needham Buy
2015-06-03 Iniziato Raymond James Strong Buy
2014-07-21 Iniziato Needham Buy
Mostra tutto

Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie

pulisher
09:54 AM

Will Amphastar Pharmaceuticals Inc. (29A) stock gain from lower interest ratesJuly 2025 Setups & Entry and Exit Point Strategies - newser.com

09:54 AM
pulisher
Oct 09, 2025

BofA Cuts Price Target on Amphastar Pharmaceuticals to $31 From $32 - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Benzinga

Oct 09, 2025
pulisher
Oct 09, 2025

Can Amphastar Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Volume Report & Daily Entry Point Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How to monitor Amphastar Pharmaceuticals Inc. with trend dashboardsQuarterly Risk Review & Safe Capital Growth Trade Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will Amphastar Pharmaceuticals Inc. stock recover after recent dropMarket Volume Summary & Expert Curated Trade Setups - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Amphastar Pharmaceuticals' (AMPH) Hold (C-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 08, 2025
pulisher
Oct 06, 2025

Will Amphastar Pharmaceuticals Inc. (29A) stock return to pre crash levels2025 Volume Leaders & Growth Focused Entry Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

What analysts say about Cochlear Limited OC5 stockIPO Market Watch & Zero-Cost Stock Research by Professionals - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

Momentum divergence signals in Amphastar Pharmaceuticals Inc. chartAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Why Amphastar Pharmaceuticals Inc. stock is a value investor pickJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference - 富途牛牛

Oct 04, 2025
pulisher
Oct 03, 2025

Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competitionEarnings Recap Report & Free High Return Stock Watch Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Amphastar Pharmaceuticals Inc. (29A) stock cheap vs fundamentalsEarnings Trend Report & Expert Approved Momentum Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Does Amphastar Pharmaceuticals Inc. stock trade at a discount to peersMarket Growth Review & Low Drawdown Investment Ideas - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells 500 Shares - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

What drives Amphastar Pharmaceuticals Inc 29A stock pricePrice Support Zones & Free Get High Impact Recommendations - earlytimes.in

Oct 02, 2025
pulisher
Sep 30, 2025

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 21.35% Potential Upside - DirectorsTalk Interviews

Sep 30, 2025
pulisher
Sep 28, 2025

What analysts say about Amphastar Pharmaceuticals Inc stockPrice Momentum Alerts & Small Entry Cost Portfolio - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

What analysts say about Amphastar Pharmaceuticals Inc 29A stockMarket Sentiment Extremes & Breakout Stock Alerts - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

What drives Amphastar Pharmaceuticals Inc stock priceValue Traps to Avoid & Outstanding Return Stocks - earlytimes.in

Sep 27, 2025
pulisher
Sep 26, 2025

CX Institutional Has $6.05 Million Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Sep 26, 2025
pulisher
Sep 24, 2025

CX Institutional Increases Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Sep 24, 2025
pulisher
Sep 23, 2025

Analysts Set Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Price Target at $31.60 - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

After Protracted Sell-Off, Amphastar Looks Like A Value Pick (NASDAQ:AMPH) - Seeking Alpha

Sep 23, 2025
pulisher
Sep 23, 2025

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring 17.13% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews

Sep 23, 2025
pulisher
Sep 20, 2025

Aug Big Picture: Is Amphastar Pharmaceuticals Inc stock a top performer YTD2025 Sector Review & Weekly Setup with ROI Potential - خودرو بانک

Sep 20, 2025
pulisher
Sep 19, 2025

Tech Rally: Can Kiora Pharmaceuticals Inc maintain sales growthWeekly Stock Analysis & Real-Time Market Sentiment Reports - khodrobank.com

Sep 19, 2025

Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$19.76
price down icon 1.54%
$9.74
price down icon 2.50%
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
$136.63
price down icon 1.33%
$440.00
price down icon 1.21%
Capitalizzazione:     |  Volume (24 ore):